A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

NCT00013572 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

NCT00000868 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

NCT00007332 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa

NCT00498056 ·Status: WITHDRAWN ·Phase: PHASE2

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm

NCT00076817 ·Status: COMPLETED ·Phase: PHASE1

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

NCT00011011 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

NCT00002402 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

NCT00000755 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines

NCT00000746 ·Status: COMPLETED ·Phase: PHASE1

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

NCT00011037 ·Status: COMPLETED ·Phase: PHASE2

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

NCT00083603 ·Status: COMPLETED ·Phase: PHASE1

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers

NCT00490074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019)

NCT00894114 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

NCT00472719 ·Status: COMPLETED ·Phase: PHASE1

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

NCT00005779 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination

NCT00005758 ·Status: COMPLETED ·Phase: PHASE3

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

NCT00415649 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults

NCT00001052 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

NCT00801697 ·Status: COMPLETED ·Phase: PHASE1

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

NCT00006495 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants

NCT03122223 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

NCT01386489 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

NCT00001044 ·Status: COMPLETED ·Phase: PHASE1